LeadIQ logo
Learn more at LeadIQ.com
Eikonizo Therapeutics logo

Eikonizo Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Eikonizo Therapeutics is a biotechnology research company located at 700 Main Street, North Cambridge, Massachusetts 02139, United States, with 11-50 employees. The company develops brain-penetrant small molecules and uses in vivo target engagement techniques to accelerate the identification of therapeutics. Its initial program is focused on a disease-modifying therapeutic for neurodegenerative diseases. In December 2024, Novo Nordisk A/S invested in Eikonizo, and related governance and leadership appointments were announced, indicating external collaboration. More information is available on the company website at https://eikonizo.com.

Find Eikonizo Therapeutics employees' phone numbers or email addresses

Eikonizo Therapeutics Global Highlights

Location
Employees

North America
13

Minus sign iconPlus sign icon
  • United States Of America
    13

Europe
1

Minus sign iconPlus sign icon
  • Denmark
    1

Eikonizo Therapeutics's Leadership

  • Brain-Penetrant Small Molecules at Eikonizo Therapeutics
    T. G.
    Brain-Penetrant Small Molecules
    Mobile Phone
  • Employee at Eikonizo Therapeutics
    H.
    Mobile Phone
  • Employee at Eikonizo Therapeutics
    R. S.
    Mobile Phone

Eikonizo Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Business
  • Biotechnology
  • Accounting
  • Consultant
  • Other

Contact profiles from Eikonizo Therapeutics

Name
Title
Contact
Location
Last Update
  • Brain-Penetrant Small Molecules at Eikonizo Therapeutics
    T. G.
    Brain-Penetrant Small Molecules
    Mobile Phone
    Oct 22, 2024
  • Employee at Eikonizo Therapeutics
    H.
    Mobile Phone
    Jul 28, 2023
  • Employee at Eikonizo Therapeutics
    R. S.
    Mobile Phone
    Jul 28, 2023

Frequently Asked Questions

What is Eikonizo Therapeutics known for?

Minus sign iconPlus sign iconEikonizo Therapeutics was founded in 2017 and operates in the Biotechnology Research industry. Explore Eikonizo Therapeutics's company overview page for more information.

What is Eikonizo Therapeutics's most common email format?

Minus sign iconPlus sign iconEikonizo Therapeutics employees' email format typically follows the pattern of First.Last@eikonizo.com. Trying to find reliable and up-to-date employee contact data? Find more Eikonizo Therapeutics email formats with LeadIQ.

How many employees does Eikonizo Therapeutics have currently?

Minus sign iconPlus sign iconEikonizo Therapeutics has approximately 13 employees as of August 2026. These team members are located across 2 continents, including North America and Europe.

Who are Eikonizo Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Eikonizo Therapeutics's key employees include:

  • Brain-Penetrant Small Molecules: T. G.
  • : H.
  • : R. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

  • B2B data verified in real-time
  • Sync data to your CRM, & add it to an outreach sequence in one click
  • Integrations with your tech stack for optimal efficiency
  • A patented AI cold email generator
  • Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.